Related Experiment Video
Updated: Sep 20, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Overexpression of BAD preferentially augments anoikis
Masashi Idogawa1, Masaaki Adachi, Takae Minami
1First Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan.
Abstract:
BAD is a BH3-only protein, and its proapoptotic activity is negatively regulated by serine phosphorylation. Here, we show that overexpression of BAD preferentially augments anchorage loss-induced apoptosis (anoikis). Gene transfer-mediated BAD overexpression alone did not induce apoptosis in attached MDCK cells but strongly augmented apoptosis when cells were cultured in suspension. In contrast, overexpression of another BH3-only protein, BID, displayed much lower augmentation of anoikis, suggesting a preferential contribution of BAD to anoikis. During suspension culture, unphosphorylated BAD was gradually increased and targeted to the mitochondria. Cotransfection of BAD with constitutively active Akt cDNA strongly inhibited this change. In contrast, the increase of unphosphorylated BAD was not significantly inhibited by several phosphatase inhibitors or cotransfection with a dominant negative calcineurin cDNA, implying that the increase may be mainly due to a decrease of serine kinase activity, such as that of Akt. Similar results were observed in COS-7 cells, suggesting that BAD overexpression can increase sensitivity of anchorage-dependent cancer cells to anoikis. Thus, we propose that BAD can serve as a valuable gene therapeutic molecule to inhibit carcinoma progression.
Insights
Overexpression of BAD protein enhances anoikis, a form of apoptosis triggered by anchorage loss. This suggests BAD
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- BAD is a BH3-only protein that regulates apoptosis.
- Its activity is negatively controlled by serine phosphorylation.
Purpose of the Study:
- To investigate the role of BAD in anchorage loss-induced apoptosis (anoikis).
- To explore the potential of BAD as a gene therapeutic agent for cancer.
Main Methods:
- Gene transfer-mediated overexpression of BAD in MDCK and COS-7 cells.
- Cell culture under attached and suspended conditions.
- Analysis of BAD phosphorylation and subcellular localization.
- Cotransfection with Akt cDNA and dominant-negative calcineurin.
Main Results:
- BAD overexpression preferentially augmented anoikis in suspended cells.
- Unphosphorylated BAD increased and localized to mitochondria during suspension culture.
- Akt activity inhibited the increase in unphosphorylated BAD, while phosphatases did not.
- BAD overexpression increased cancer cell sensitivity to anoikis.
Conclusions:
- BAD plays a preferential role in anoikis.
- Akt-mediated phosphorylation regulates BAD's contribution to anoikis.
- BAD holds potential as a gene therapy target to inhibit carcinoma progression.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Apoptosis
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Abnormal Proliferation